GLP-1 Drugs May Reduce Addiction Risk

New research reveals that weight-loss drugs like Ozempic and Wegovy may do far more than help you lose weight—they’re linked to a significantly lower risk of developing substance use disorders, including alcohol, nicotine, cannabis, cocaine, and opioids. A massive study of over 600,000 veterans found a 14% overall reduction in addiction risk, with even stronger effects for opioids, cocaine, and nicotine. For those already battling addiction, the drugs also cut serious outcomes like ER visits, hospitalizations, overdoses, and deaths. Scientists believe these medications may target a shared biological pathway that drives cravings across substances, possibly by quieting the brain’s reward system. This could revolutionize addiction treatment by offering a one-size-fits-most approach to tackling cravings at their root. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/bc9b210b030404d3